AIM: To study the effect of maternal pre-eclampsia on cord plasma leptin concentrations in preterm infants. METHODS: Leptin concentration was analysed in cord plasma of 74 preterm infants, gestational age 24 to 32 weeks. Of these, 14 were born to pre-eclamptic mothers, in 10 intrauterine growth retardation (IUGR) was present, and 59 had been exposed antenatally to corticosteroids. RESULTS: The mean (SD) concentration of cord plasma leptin was 1.31 (0.88) microg/l. A significant correlation was found between leptin concentration and gestational age (r = 0.336; p = 0.0037). Leptin levels were higher in infants of pre-eclamptic mothers (p = 0.0007), in those with IUGR (p = 0.0005), and in infants exposed antenatally to corticosteroids (p = 0.02). In multiple regression analysis, leptin was associated with gestational age and maternal pre-eclampsia (both p < 0.05), but not with antenatal corticosteroids. CONCLUSIONS: Increased fetal leptin in maternal pre-eclampsia may reflect a physiological adaptation to fetal stress such as hypoxia.
AIM: To study the effect of maternal pre-eclampsia on cord plasma leptin concentrations in preterm infants. METHODS: Leptin concentration was analysed in cord plasma of 74 preterm infants, gestational age 24 to 32 weeks. Of these, 14 were born to pre-eclamptic mothers, in 10 intrauterine growth retardation (IUGR) was present, and 59 had been exposed antenatally to corticosteroids. RESULTS: The mean (SD) concentration of cord plasma leptin was 1.31 (0.88) microg/l. A significant correlation was found between leptin concentration and gestational age (r = 0.336; p = 0.0037). Leptin levels were higher in infants of pre-eclamptic mothers (p = 0.0007), in those with IUGR (p = 0.0005), and in infants exposed antenatally to corticosteroids (p = 0.02). In multiple regression analysis, leptin was associated with gestational age and maternal pre-eclampsia (both p < 0.05), but not with antenatal corticosteroids. CONCLUSIONS: Increased fetal leptin in maternal pre-eclampsia may reflect a physiological adaptation to fetal stress such as hypoxia.
Authors: H A Koistinen; V A Koivisto; S Andersson; S L Karonen; K Kontula; L Oksanen; K A Teramo Journal: J Clin Endocrinol Metab Date: 1997-10 Impact factor: 5.958
Authors: N Hoggard; L Hunter; J S Duncan; L M Williams; P Trayhurn; J G Mercer Journal: Proc Natl Acad Sci U S A Date: 1997-09-30 Impact factor: 11.205
Authors: S R Bornstein; J Licinio; R Tauchnitz; L Engelmann; A B Negrão; P Gold; G P Chrousos Journal: J Clin Endocrinol Metab Date: 1998-01 Impact factor: 5.958
Authors: P S Shekhawat; J S Garland; C Shivpuri; G J Mick; P Sasidharan; C J Pelz; K L McCormick Journal: Pediatr Res Date: 1998-03 Impact factor: 3.756
Authors: M R Sierra-Honigmann; A K Nath; C Murakami; G García-Cardeña; A Papapetropoulos; W C Sessa; L A Madge; J S Schechner; M B Schwabb; P J Polverini; J R Flores-Riveros Journal: Science Date: 1998-09-11 Impact factor: 47.728
Authors: S Zhang; L Wang; J Leng; H Liu; W Li; T Zhang; N Li; W Li; H Tian; A A Baccarelli; L Hou; G Hu Journal: J Hum Hypertens Date: 2017-03-16 Impact factor: 3.012
Authors: Rawan A Obeidat; Nour Abdo; Baraa Sakee; Shahed Alghazo; Omar F Jbarah; Ethar A Hazaimeh; Soha Albeitawi Journal: Ann Med Surg (Lond) Date: 2021-11-14
Authors: Elizabeth M Kennedy; Karen Hermetz; Amber Burt; Todd M Everson; Maya Deyssenroth; Ke Hao; Jia Chen; Margaret R Karagas; Dong Pei; Devin C Koestler; Carmen J Marsit Journal: Epigenetics Date: 2020-10-04 Impact factor: 4.528